Company Filing History:
2 out of 1,979 
1 out of 215 Years Active: 2006-2007
Title: Hossen Mahmud: Innovator in CCR4 Modulation
Introduction
Hossen Mahmud is a notable inventor based in San Antonio, TX (US). He has made significant contributions to the field of chemokine receptor research, particularly focusing on the CCR4 receptor. With a total of 2 patents, Mahmud's work is aimed at addressing various diseases associated with CCR4 activity.
Latest Patents
Mahmud's latest patents include innovative compounds and compositions that bind to the CCR4 chemokine receptor. These inventions are particularly useful for treating diseases related to CCR4 activity, such as contact hypersensitivity. His patents also encompass CCR4 antagonists, which provide methods for treating chemokine receptor-mediated conditions. The subject compounds are designed to modulate CCR4 function or a CCR4-mediated response, making them valuable for the treatment or prevention of inflammatory conditions and diseases.
Career Highlights
Throughout his career, Hossen Mahmud has worked with prominent companies in the biotechnology sector. Notably, he has been associated with Amgen Inc. and Chemocentryx, Inc., where he has contributed to groundbreaking research and development efforts.
Collaborations
Mahmud has collaborated with several professionals in his field, including Tassie Collins and Julio Cesar Medina. These collaborations have further enhanced his research and innovation capabilities.
Conclusion
Hossen Mahmud's contributions to CCR4 modulation represent significant advancements in the treatment of various diseases. His innovative patents and collaborations highlight his commitment to improving healthcare through scientific research.